Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharming Group N.V (PHAR) Share-based Compensation (IS): 2024

Historic Share-based Compensation (IS) for Pharming Group N.V (PHAR) over the last 1 years, with Dec 2024 value amounting to -$5.5 million.

  • Pharming Group N.V's Share-based Compensation (IS) was N/A to -$5.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $11.2 million, marking a year-over-year change of. This contributed to the annual value of $11.2 million for FY2024, which is N/A change from last year.
  • Pharming Group N.V's Share-based Compensation (IS) amounted to -$5.5 million in Q4 2024, which was down 163.58% from $8.6 million recorded in Q3 2024.
  • Pharming Group N.V's Share-based Compensation (IS)'s 5-year high stood at $8.6 million during Q3 2024, with a 5-year trough of -$5.5 million in Q4 2024.
  • For the 1-year period, Pharming Group N.V's Share-based Compensation (IS) averaged around $2.8 million, with its median value being $4.1 million (2024).